Statements (58)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:superhero
|
gptkbp:approves |
gptkb:2014
gptkb:FDA |
gptkbp:care_instructions |
shake before use
prime before first use |
gptkbp:clinical_trial |
maintenance therapy
demonstrated efficacy well tolerated long-term management rescue therapy reduced exacerbations showed improved lung function |
gptkbp:delivers |
gptkb:drug
|
gptkbp:education |
requires training
important for proper use |
gptkbp:features |
lightweight design
ergonomic grip dose indicator easy-to-read instructions |
gptkbp:feedback |
generally positive
improved adherence preferred over traditional inhalers satisfaction with delivery system |
gptkbp:formulation |
aerosol
|
https://www.w3.org/2000/01/rdf-schema#label |
Respimat
|
gptkbp:ingredients |
olodaterol
tiotropium |
gptkbp:invention |
patented
|
gptkbp:is_available_in |
multiple flavors
various strengths |
gptkbp:is_compared_to |
nebulizers
metered-dose inhalers |
gptkbp:is_designed_for |
easy handling
consistent dosing |
gptkbp:is_used_for |
gptkb:asthma
chronic obstructive pulmonary disease |
gptkbp:maintenance |
clean regularly
replace cartridge as needed |
gptkbp:manager |
inhalation
|
gptkbp:manufacturer |
gptkb:Boehringer_Ingelheim
|
gptkbp:marketed_as |
Respimat Soft Mist Inhaler
|
gptkbp:population |
gptkb:Person
adults |
gptkbp:provides_information_on |
used in combination therapy
recommended for COPD recommended for asthma used in stepwise approach |
gptkbp:regulatory_compliance |
approved for use in multiple countries
|
gptkbp:side_effect |
headache
nausea cough dry mouth throat irritation |
gptkbp:storage |
room temperature
protected from light |
gptkbp:technology |
soft mist inhaler
|
gptkbp:bfsParent |
gptkb:Combivent_Respimat
|
gptkbp:bfsLayer |
6
|